Summary
This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
According to APO Research, The global Mesalazine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Mesalazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Mesalazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Mesalazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Mesalazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm and Lasa Loboratory, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Mesalazine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mesalazine, also provides the sales of main regions and countries. Of the upcoming market potential for Mesalazine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mesalazine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Mesalazine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Mesalazine sales, projected growth trends, production technology, application and end-user industry.
Mesalazine segment by Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Mesalazine segment by Purity
Above 97 %
Above 98 %
Above 99 %
Mesalazine segment by Application
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
Mesalazine segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesalazine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mesalazine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesalazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Mesalazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
- Market Overview
- Product Definition
- Global Mesalazine Market Size, 2019 VS 2023 VS 2030
- Global Mesalazine Market Size Estimates and Forecasts (2019-2030)
- Global Mesalazine Sales Estimates and Forecasts (2019-2030)
- Global Mesalazine Market Average Price (2019-2030)
- Assumptions and Limitations
- Study Goals and Objectives
- Global Mesalazine Market Dynamics
- Mesalazine Industry Trends
- Mesalazine Industry Drivers
- Mesalazine Industry Opportunities and Challenges
- Mesalazine Industry Restraints
- Mesalazine Market by Manufacturers
- Global Mesalazine Revenue by Manufacturers (2019-2024)
- Global Mesalazine Sales by Manufacturers (2019-2024)
- Global Mesalazine Average Sales Price by Manufacturers (2019-2024)
- Global Mesalazine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
- Global Mesalazine Key Manufacturers Manufacturing Sites & Headquarters
- Global Mesalazine Manufacturers, Product Type & Application
- Global Mesalazine Manufacturers Commercialization Time
- Market Competitive Analysis
- Global Mesalazine Market CR5 and HHI
- Global Top 5 and 10 Mesalazine Players Market Share by Revenue in 2023
- 2023 Mesalazine Tier 1, Tier 2, and Tier 3
- Mesalazine Market by Type
- Mesalazine Type Introduction
- Above 97 %
- Above 98 %
- Above 99 %
- Global Mesalazine Sales by Type
- Global Mesalazine Sales by Type (2019 VS 2023 VS 2030)
- Global Mesalazine Sales by Type (2019-2030)
- Global Mesalazine Sales Market Share by Type (2019-2030)
- Global Mesalazine Revenue by Type
- Global Mesalazine Revenue by Type (2019 VS 2023 VS 2030)
- Global Mesalazine Revenue by Type (2019-2030)
- Global Mesalazine Revenue Market Share by Type (2019-2030)
- Mesalazine Type Introduction
- Mesalazine Market by Application
- Mesalazine Application Introduction
- Tablets
- Capsules
- Pellet and Granule
- Suppository
- Enema
- Others
- Global Mesalazine Sales by Application
- Global Mesalazine Sales by Application (2019 VS 2023 VS 2030)
- Global Mesalazine Sales by Application (2019-2030)
- Global Mesalazine Sales Market Share by Application (2019-2030)
- Global Mesalazine Revenue by Application
- Global Mesalazine Revenue by Application (2019 VS 2023 VS 2030)
- Global Mesalazine Revenue by Application (2019-2030)
- Global Mesalazine Revenue Market Share by Application (2019-2030)
- Mesalazine Application Introduction
- Global Mesalazine Sales by Region
- Global Mesalazine Sales by Region: 2019 VS 2023 VS 2030
- Global Mesalazine Sales by Region (2019-2030)
- Global Mesalazine Sales by Region (2019-2024)
- Global Mesalazine Sales Forecasted by Region (2025-2030)
- North America
- North America Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- North America Mesalazine Sales by Country (2019-2030)
- U.S.
- Canada
- Europe
- Europe Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- Europe Mesalazine Sales by Country (2019-2030)
- Germany
- France
- U.K.
- Italy
- Netherlands
- Asia Pacific
- Asia Pacific Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- Asia Pacific Mesalazine Sales by Country (2019-2030)
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- LAMEA
- LAMEA Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- LAMEA Mesalazine Sales by Country (2019-2030)
- Mexico
- Brazil
- Turkey
- GCC Countries
- Global Mesalazine Revenue by Region
- Global Mesalazine Revenue by Region
- Global Mesalazine Revenue by Region: 2019 VS 2023 VS 2030
- Global Mesalazine Revenue by Region (2019-2024)
- Global Mesalazine Revenue by Region (2025-2030)
- Global Mesalazine Revenue Market Share by Region (2019-2030)
- North America
- North America Mesalazine Revenue (2019-2030)
- North America Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030
- Europe
- Europe Mesalazine Revenue (2019-2030)
- Europe Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030
- Asia-Pacific
- Asia-Pacific Mesalazine Revenue (2019-2030)
- Asia-Pacific Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030
- LAMEA
- LAMEA Mesalazine Revenue (2019-2030)
- LAMEA Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030
- Global Mesalazine Revenue by Region
- Company Profiles
- PharmaZell
- PharmaZell Comapny Information
- PharmaZell Business Overview
- PharmaZell Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- PharmaZell Mesalazine Product Portfolio
- PharmaZell Recent Developments
- Syntese A/S
- Syntese A/S Comapny Information
- Syntese A/S Business Overview
- Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Syntese A/S Mesalazine Product Portfolio
- Syntese A/S Recent Developments
- Cambrex Corporation
- Cambrex Corporation Comapny Information
- Cambrex Corporation Business Overview
- Cambrex Corporation Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Cambrex Corporation Mesalazine Product Portfolio
- Cambrex Corporation Recent Developments
- Divis Laboratories
- Divis Laboratories Comapny Information
- Divis Laboratories Business Overview
- Divis Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Divis Laboratories Mesalazine Product Portfolio
- Divis Laboratories Recent Developments
- Chemi SpA
- Chemi SpA Comapny Information
- Chemi SpA Business Overview
- Chemi SpA Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Chemi SpA Mesalazine Product Portfolio
- Chemi SpA Recent Developments
- Ipca Laboratories
- Ipca Laboratories Comapny Information
- Ipca Laboratories Business Overview
- Ipca Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Ipca Laboratories Mesalazine Product Portfolio
- Ipca Laboratories Recent Developments
- Hangzhou Brother
- Hangzhou Brother Comapny Information
- Hangzhou Brother Business Overview
- Hangzhou Brother Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Hangzhou Brother Mesalazine Product Portfolio
- Hangzhou Brother Recent Developments
- Lianyungang Fengheng Biopharm
- Lianyungang Fengheng Biopharm Comapny Information
- Lianyungang Fengheng Biopharm Business Overview
- Lianyungang Fengheng Biopharm Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
- Lianyungang Fengheng Biopharm Recent Developments
- Lasa Loboratory
- Lasa Loboratory Comapny Information
- Lasa Loboratory Business Overview
- Lasa Loboratory Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Lasa Loboratory Mesalazine Product Portfolio
- Lasa Loboratory Recent Developments
- Corden Pharma Bergamo
- Corden Pharma Bergamo Comapny Information
- Corden Pharma Bergamo Business Overview
- Corden Pharma Bergamo Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Corden Pharma Bergamo Mesalazine Product Portfolio
- Corden Pharma Bergamo Recent Developments
- Erregierre SpA
- Erregierre SpA Comapny Information
- Erregierre SpA Business Overview
- Erregierre SpA Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Erregierre SpA Mesalazine Product Portfolio
- Erregierre SpA Recent Developments
- CTX Lifescience
- CTX Lifescience Comapny Information
- CTX Lifescience Business Overview
- CTX Lifescience Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- CTX Lifescience Mesalazine Product Portfolio
- CTX Lifescience Recent Developments
- Ishita Active Pharma Ingredients
- Ishita Active Pharma Ingredients Comapny Information
- Ishita Active Pharma Ingredients Business Overview
- Ishita Active Pharma Ingredients Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Ishita Active Pharma Ingredients Mesalazine Product Portfolio
- Ishita Active Pharma Ingredients Recent Developments
- YC Biotech (Jiangsu)
- YC Biotech (Jiangsu) Comapny Information
- YC Biotech (Jiangsu) Business Overview
- YC Biotech (Jiangsu) Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- YC Biotech (Jiangsu) Mesalazine Product Portfolio
- YC Biotech (Jiangsu) Recent Developments
- Xinxiang Tianfeng Fine Chemical
- Xinxiang Tianfeng Fine Chemical Comapny Information
- Xinxiang Tianfeng Fine Chemical Business Overview
- Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Price, Revenue and Gross Margin (2019-2024)
- Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
- Xinxiang Tianfeng Fine Chemical Recent Developments
- PharmaZell
- Value Chain and Sales Channels Analysis
- Mesalazine Value Chain Analysis
- Mesalazine Key Raw Materials
- Raw Materials Key Suppliers
- Manufacturing Cost Structure
- Mesalazine Production Mode & Process
- Mesalazine Sales Channels Analysis
- Direct Comparison with Distribution Share
- Mesalazine Distributors
- Mesalazine Customers
- Mesalazine Value Chain Analysis
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
- Disclaimer
List of Tables
Table 1 | :Mesalazine Industry Trends |
Table 2 | :Mesalazine Industry Drivers |
Table 3 | :Mesalazine Industry Opportunities and Challenges |
Table 4 | :Mesalazine Industry Restraints |
Table 5 | :Global Mesalazine Revenue by Manufacturers (US$ Million) & (2019-2024) |
Table 6 | :Global Mesalazine Revenue Market Share by Manufacturers (2019-2024) |
Table 7 | :Global Mesalazine Sales by Manufacturers (Ton) & (2019-2024) |
Table 8 | :Global Mesalazine Sales Market Share by Manufacturers |
Table 9 | :Global Mesalazine Average Sales Price (US$/Kg) of Manufacturers (2019-2024) |
Table 10 | :Global Mesalazine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024 |
Table 11 | :Global Mesalazine Key Manufacturers Manufacturing Sites & Headquarters |
Table 12 | :Global Mesalazine Manufacturers, Product Type & Application |
Table 13 | :Global Mesalazine Manufacturers Commercialization Time |
Table 14 | :Global Manufacturers Market Concentration Ratio (CR5 and HHI) |
Table 15 | :Global Mesalazine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023) |
Table 16 | :Major Manufacturers of Above 97 % |
Table 17 | :Major Manufacturers of Above 98 % |
Table 18 | :Major Manufacturers of Above 99 % |
Table 19 | :Global Mesalazine Sales by Type 2019 VS 2023 VS 2030 (Ton) |
Table 20 | :Global Mesalazine Sales by Type (2019-2024) & (Ton) |
Table 21 | :Global Mesalazine Sales by Type (2025-2030) & (Ton) |
Table 22 | :Global Mesalazine Sales Market Share by Type (2019-2024) |
Table 23 | :Global Mesalazine Sales Market Share by Type (2025-2030) |
Table 24 | :Global Mesalazine Revenue by Type 2019 VS 2023 VS 2030 (Ton) |
Table 25 | :Global Mesalazine Revenue by Type (2019-2024) & (Ton) |
Table 26 | :Global Mesalazine Revenue by Type (2025-2030) & (Ton) |
Table 27 | :Global Mesalazine Revenue Market Share by Type (2019-2024) |
Table 28 | :Global Mesalazine Revenue Market Share by Type (2025-2030) |
Table 29 | :Major Manufacturers of Tablets |
Table 30 | :Major Manufacturers of Capsules |
Table 31 | :Major Manufacturers of Pellet and Granule |
Table 32 | :Major Manufacturers of Suppository |
Table 33 | :Major Manufacturers of Enema |
Table 34 | :Major Manufacturers of Others |
Table 35 | :Global Mesalazine Sales by Application 2019 VS 2023 VS 2030 (Ton) |
Table 36 | :Global Mesalazine Sales by Application (2019-2024) & (Ton) |
Table 37 | :Global Mesalazine Sales by Application (2025-2030) & (Ton) |
Table 38 | :Global Mesalazine Sales Market Share by Application (2019-2024) |
Table 39 | :Global Mesalazine Sales Market Share by Application (2025-2030) |
Table 40 | :Global Mesalazine Revenue by Application 2019 VS 2023 VS 2030 (Ton) |
Table 41 | :Global Mesalazine Revenue by Application (2019-2024) & (Ton) |
Table 42 | :Global Mesalazine Revenue by Application (2025-2030) & (Ton) |
Table 43 | :Global Mesalazine Revenue Market Share by Application (2019-2024) |
Table 44 | :Global Mesalazine Revenue Market Share by Application (2025-2030) |
Table 45 | :Global Mesalazine Sales by Region: 2019 VS 2023 VS 2030 (Ton) |
Table 46 | :Global Mesalazine Sales by Region (2019-2024) & (Ton) |
Table 47 | :Global Mesalazine Sales Market Share by Region (2019-2024) |
Table 48 | :Global Mesalazine Sales Forecasted by Region (2025-2030) & (Ton) |
Table 49 | :Global Mesalazine Sales Forecasted Market Share by Region (2025-2030) |
Table 50 | :North America Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton) |
Table 51 | :North America Mesalazine Sales by Country (2019-2024) & (Ton) |
Table 52 | :North America Mesalazine Sales by Country (2025-2030) & (Ton) |
Table 53 | :Europe Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton) |
Table 54 | :Europe Mesalazine Sales by Country (2019-2024) & (Ton) |
Table 55 | :Europe Mesalazine Sales by Country (2025-2030) & (Ton) |
Table 56 | :Asia Pacific Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton) |
Table 57 | :Asia Pacific Mesalazine Sales by Country (2019-2024) & (Ton) |
Table 58 | :Asia Pacific Mesalazine Sales by Country (2025-2030) & (Ton) |
Table 59 | :LAMEA Mesalazine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton) |
Table 60 | :LAMEA Mesalazine Sales by Country (2019-2024) & (Ton) |
Table 61 | :LAMEA Mesalazine Sales by Country (2025-2030) & (Ton) |
Table 62 | :Global Mesalazine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) |
Table 63 | :Global Mesalazine Revenue by Region (2019-2024) & (US$ Million) |
Table 64 | :Global Mesalazine Revenue by Region (2025-2030) & (US$ Million) |
Table 65 | :Global Mesalazine Revenue Market Share by Region (2019-2024) |
Table 66 | :Global Mesalazine Revenue Market Share by Region (2025-2030) |
Table 67 | :PharmaZell Company Information |
Table 68 | :PharmaZell Business Overview |
Table 69 | :PharmaZell Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 70 | :PharmaZell Mesalazine Product Portfolio |
Table 71 | :PharmaZell Recent Development |
Table 72 | :Syntese A/S Company Information |
Table 73 | :Syntese A/S Business Overview |
Table 74 | :Syntese A/S Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 75 | :Syntese A/S Mesalazine Product Portfolio |
Table 76 | :Syntese A/S Recent Development |
Table 77 | :Cambrex Corporation Company Information |
Table 78 | :Cambrex Corporation Business Overview |
Table 79 | :Cambrex Corporation Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 80 | :Cambrex Corporation Mesalazine Product Portfolio |
Table 81 | :Cambrex Corporation Recent Development |
Table 82 | :Divis Laboratories Company Information |
Table 83 | :Divis Laboratories Business Overview |
Table 84 | :Divis Laboratories Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 85 | :Divis Laboratories Mesalazine Product Portfolio |
Table 86 | :Divis Laboratories Recent Development |
Table 87 | :Chemi SpA Company Information |
Table 88 | :Chemi SpA Business Overview |
Table 89 | :Chemi SpA Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 90 | :Chemi SpA Mesalazine Product Portfolio |
Table 91 | :Chemi SpA Recent Development |
Table 92 | :Ipca Laboratories Company Information |
Table 93 | :Ipca Laboratories Business Overview |
Table 94 | :Ipca Laboratories Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 95 | :Ipca Laboratories Mesalazine Product Portfolio |
Table 96 | :Ipca Laboratories Recent Development |
Table 97 | :Hangzhou Brother Company Information |
Table 98 | :Hangzhou Brother Business Overview |
Table 99 | :Hangzhou Brother Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 100 | :Hangzhou Brother Mesalazine Product Portfolio |
Table 101 | :Hangzhou Brother Recent Development |
Table 102 | :Lianyungang Fengheng Biopharm Company Information |
Table 103 | :Lianyungang Fengheng Biopharm Business Overview |
Table 104 | :Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 105 | :Lianyungang Fengheng Biopharm Mesalazine Product Portfolio |
Table 106 | :Lianyungang Fengheng Biopharm Recent Development |
Table 107 | :Lasa Loboratory Company Information |
Table 108 | :Lasa Loboratory Business Overview |
Table 109 | :Lasa Loboratory Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 110 | :Lasa Loboratory Mesalazine Product Portfolio |
Table 111 | :Lasa Loboratory Recent Development |
Table 112 | :Corden Pharma Bergamo Company Information |
Table 113 | :Corden Pharma Bergamo Business Overview |
Table 114 | :Corden Pharma Bergamo Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 115 | :Corden Pharma Bergamo Mesalazine Product Portfolio |
Table 116 | :Corden Pharma Bergamo Recent Development |
Table 117 | :Erregierre SpA Company Information |
Table 118 | :Erregierre SpA Business Overview |
Table 119 | :Erregierre SpA Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 120 | :Erregierre SpA Mesalazine Product Portfolio |
Table 121 | :Erregierre SpA Recent Development |
Table 122 | :CTX Lifescience Company Information |
Table 123 | :CTX Lifescience Business Overview |
Table 124 | :CTX Lifescience Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 125 | :CTX Lifescience Mesalazine Product Portfolio |
Table 126 | :CTX Lifescience Recent Development |
Table 127 | :Ishita Active Pharma Ingredients Company Information |
Table 128 | :Ishita Active Pharma Ingredients Business Overview |
Table 129 | :Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 130 | :Ishita Active Pharma Ingredients Mesalazine Product Portfolio |
Table 131 | :Ishita Active Pharma Ingredients Recent Development |
Table 132 | :YC Biotech (Jiangsu) Company Information |
Table 133 | :YC Biotech (Jiangsu) Business Overview |
Table 134 | :YC Biotech (Jiangsu) Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 135 | :YC Biotech (Jiangsu) Mesalazine Product Portfolio |
Table 136 | :YC Biotech (Jiangsu) Recent Development |
Table 137 | :Xinxiang Tianfeng Fine Chemical Company Information |
Table 138 | :Xinxiang Tianfeng Fine Chemical Business Overview |
Table 139 | :Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2019-2024) |
Table 140 | :Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio |
Table 141 | :Xinxiang Tianfeng Fine Chemical Recent Development |
Table 142 | :Key Raw Materials |
Table 143 | :Raw Materials Key Suppliers |
Table 144 | :Mesalazine Distributors List |
Table 145 | :Mesalazine Customers List |
Table 146 | :Research Programs/Design for This Report |
Table 147 | :Authors List of This Report |
Table 148 | :Secondary Sources |
Table 149 | :Primary Sources |
List of Figures
Figure 1 | :Mesalazine Product Picture |
Figure 2 | :Global Mesalazine Market Size (US$ Million), 2019 VS 2023 VS 2030 |
Figure 3 | :Global Mesalazine Market Size (2019-2030) & (US$ Million) |
Figure 4 | :Global Mesalazine Sales (2019-2030) & (Ton) |
Figure 5 | :Global Mesalazine Average Price (US$/Kg) & (2019-2030) |
Figure 6 | :Global Top 5 and 10 Mesalazine Players Market Share by Revenue in 2023 |
Figure 7 | :Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 |
Figure 8 | :Above 97 % Picture |
Figure 9 | :Above 98 % Picture |
Figure 10 | :Above 99 % Picture |
Figure 11 | :Global Mesalazine Sales by Type (2019 VS 2023 VS 2030) & (Ton) |
Figure 12 | :Global Mesalazine Sales Market Share 2019 VS 2023 VS 2030 |
Figure 13 | :Global Mesalazine Sales Market Share by Type (2019-2030) |
Figure 14 | :Global Mesalazine Revenue by Type (2019 VS 2023 VS 2030) & (Ton) |
Figure 15 | :Global Mesalazine Revenue Market Share 2019 VS 2023 VS 2030 |
Figure 16 | :Global Mesalazine Revenue Market Share by Type (2019-2030) |
Figure 17 | :Tablets Picture |
Figure 18 | :Capsules Picture |
Figure 19 | :Pellet and Granule Picture |
Figure 20 | :Suppository Picture |
Figure 21 | :Enema Picture |
Figure 22 | :Others Picture |
Figure 23 | :Global Mesalazine Sales by Application (2019 VS 2023 VS 2030) & (Ton) |
Figure 24 | :Global Mesalazine Sales Market Share 2019 VS 2023 VS 2030 |
Figure 25 | :Global Mesalazine Sales Market Share by Application (2019-2030) |
Figure 26 | :Global Mesalazine Revenue by Application (2019 VS 2023 VS 2030) & (Ton) |
Figure 27 | :Global Mesalazine Revenue Market Share 2019 VS 2023 VS 2030 |
Figure 28 | :Global Mesalazine Revenue Market Share by Application (2019-2030) |
Figure 29 | :North America Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 30 | :North America Mesalazine Sales Market Share by Country (2019-2030) |
Figure 31 | :U.S. Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 32 | :Canada Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 33 | :Europe Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 34 | :Europe Mesalazine Sales Market Share by Country (2019-2030) |
Figure 35 | :Germany Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 36 | :France Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 37 | :U.K. Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 38 | :Italy Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 39 | :Netherlands Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 40 | :Asia Pacific Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 41 | :Asia Pacific Mesalazine Sales Market Share by Country (2019-2030) |
Figure 42 | :China Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 43 | :Japan Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 44 | :South Korea Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 45 | :Southeast Asia Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 46 | :India Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 47 | :Australia Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 48 | :LAMEA Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 49 | :LAMEA Mesalazine Sales Market Share by Country (2019-2030) |
Figure 50 | :Mexico Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 51 | :Brazil Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 52 | :Turkey Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 53 | :GCC Countries Mesalazine Sales and Growth Rate (2019-2030) & (Ton) |
Figure 54 | :Global Mesalazine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) |
Figure 55 | :Global Mesalazine Revenue Market Share by Region in Percentage: 2023 Versus 2030 |
Figure 56 | :North America Mesalazine Revenue (2019-2030) & (US$ Million) |
Figure 57 | :North America Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030 |
Figure 58 | :Europe Mesalazine Revenue (2019-2030) & (US$ Million) |
Figure 59 | :Europe Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030 |
Figure 60 | :Asia-Pacific Mesalazine Revenue (2019-2030) & (US$ Million) |
Figure 61 | :Asia-Pacific Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030 |
Figure 62 | :LAMEA Mesalazine Revenue (2019-2030) & (US$ Million) |
Figure 63 | :LAMEA Mesalazine Revenue Share by Country: 2019 VS 2023 VS 2030 |
Figure 64 | :Mesalazine Value Chain |
Figure 65 | :Manufacturing Cost Structure |
Figure 66 | :Mesalazine Production Mode & Process |
Figure 67 | :Direct Comparison with Distribution Share |
Figure 68 | :Distributors Profiles |
Figure 69 | :Years Considered |
Figure 70 | :Research Process |
Figure 71 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Pharma & Healthcare
Global Mesalazine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Pages: 196
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.